News & Training

Staburo news about trainings, events and more
Staburo Strategy 2022 – Mission

Staburo Strategy 2022 – Mission

Following our Strategy Workshop with Dr. Thilo Pfletschinger from 3DSE in May, we presented and discussed the results with all Staburo employees. Our mission statement is a short statement of our organization's purpose, identifying the scope of our operations. It...

read more
Staburo’s statistical support in oncology biomarker study

Staburo’s statistical support in oncology biomarker study

Staburo provided statistical support for a biomarker study that was recently published in the Journal Lung Cancer. The manuscript describes a retrospective analysis to assess the ability of the VeriStrat serum protein test to predict clinical benefit with afatinib...

read more
2017 B2RUN Munich

2017 B2RUN Munich

The Staburo team once again proved that it has endurance, power and a great finish. This time, for a change, not in biostatistics projects - but in the 2017 B2RUN Munich, alongside 30,000 other runners. The race track was 6.1km long and took us through the picturesque...

read more
Workshop Staburo 3DSE Biostatistics Strategy 2022

Workshop Staburo 3DSE Biostatistics Strategy 2022

With the support of Dr. Thilo Pfletschinger from 3DSE, we developed the company strategy for Staburo for the next five years. Before the workshop, all employees gave input to possible goals and the prospects of Staburo. The final strategy includes all our common goals...

read more
New member of the Staburo team

New member of the Staburo team

We are very happy to welcome Laura Schlieker in our team. Laura will support our clients with her experience in biostatistics, especially within the area of Translational Medicine & Biomarkers. We are looking forward to a great cooperation!  

read more
Staburo biostatistics support in diabetes trial

Staburo biostatistics support in diabetes trial

Another publication with Staburo biostatistics support, this time in diabetes type 2. Background: Studies of dipeptidyl peptidase (DPP)-4 inhibitors report heterogeneous effects on endothelial function in patients with type 2 diabetes (T2D). This study assessed the...

read more

You need support in data science?

Memberships and awards